Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Tony McFarland, Brian Iverson and Annie Christoff Author Article on Volcker Rule

Publications

July 18, 2014

Bass, Berry & Sims attorneys Tony McFarland, Brian Iverson and Annie Christoff authored an article for American Banker's Bank Think blog titled "How Smaller Banks Can Avoid Volcker Rule Headaches." The article suggests that the Volcker Rule's objective of preventing speculative trading by institutions "too big to fail" may have been lost in the regulatory process when the rule was expanded to banks of all sizes. To reduce the potential compliance burdens on small and mid-sized banks, the article provides three suggestions:

  1. Study the Volcker Rule regulations carefully to understand which provisions actually apply to your institution.
  2. Consider whether it is genuinely important to engage in the activities permitted under the Volcker Rule, such as proprietary risk-mitigating hedging activities.
  3. Reduce the burden of the Volcker Rule's compliance program mandate whenever possible. 

To read the full article from July 16, click here.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.